nitrazepam

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

InsomniaInfantile Spasms

153 competitors in Insomnia

#DrugCompanyPhaseTrials

1

Epidiolex

Jazz Pharmaceuticals

Phase 3

22

Neurontin

VViatris Specialty LLC

Phase 3

73

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

34

Hetlioz

VVanda Pharmaceuticals

Phase 3

25

Gaboxadol

Lundbeck

Phase 3

86

Eplivanserin

Sanofi

Phase 3

67

Volinanserin

Sanofi

Phase 3

28

Prosom

AAbbott

Phase 3

49

Org 50081

Merck & Co.

Phase 3

110

Esmirtazapine

Merck & Co.

Phase 3

4Show 27 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Insomnia1 trial

A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients

Completed·Astellas·Phase 3·NCT00374777·450 enrolled

Infantile Spasms1 trial

Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment

Completed·NNational Center for Research Resources (NCRR)·Phase 2·NCT00004758·30 enrolled

Unspecified1 trial

Pharmacovigilance in Gerontopsychiatric Patients

Terminated·HHannover Medical School·Phase 3·NCT02374567·407 enrolled

Details

Drug Info

Related News